(Q79870371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Juvenile idiopathic arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

juvenile rheumatoid arthritis

26 December 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Alberto Martini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

767-778

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

9563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Macrophage activation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Arthritis and uveitis in children. A pediatric rheumatology perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Uveitis associated with childhood rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Aortic regurgitation in seropositive juvenile arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Juvenile chronic arthritis in India: is it different from that seen in Western countries?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Clinical and therapeutic aspects of juvenile-onset spondyloarthropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

The juvenile-onset spondyloarthritides.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Psoriatic arthritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Patterns of clinical remission in select categories of juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Therapeutic criteria in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

HLA studies in IgM rheumatoid-factor-positive arthritis of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Juvenile rheumatoid arthritis as a complex genetic trait

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Genetics of juvenile idiopathic arthritis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Juvenile idiopathic arthritis genetics - what's new? What's next?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Cytokines in juvenile rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Pathogenesis of ankylosing spondylitis and reactive arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

T cell epitope-specific immune therapy for rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Proinflammatory S100 proteins in arthritis and autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Familial autoinflammatory diseases: genetics, pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Familial and acquired hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Current treatment of juvenile rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Medical treatment of juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Current management of juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

The use of methotrexate in childhood rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

The German etanercept registry for treatment of juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Leflunomide or methotrexate for juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Etanercept therapy in children with treatment-resistant uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Etanercept and uveitis in patients with juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Infliximab for juvenile idiopathic arthritis-associated uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

Do bisphosphonates make children's bones better or brittle?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

International research networks in pediatric rheumatology: the PRINTO perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960363-8

7 January 2021

10.1016/S0140-6736(07)60363-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336654%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference